NCT00661778View on ClinicalTrials.gov

A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Bevacizumab

Bevacizumab was supplied as a sterile liquid in glass vials.

DRUG

Cisplatin

Bevacizumab was supplied as a sterile liquid in glass vials.

DRUG

Docetaxel

Bevacizumab was supplied as a sterile liquid in glass vials.

Trial Locations (14)

11009

Cadiz

12002

Castellon

20080

Donostia / San Sebastian

28036

Madrid

28805

Alcalá de Henares

28935

Madrid

29010

Málaga

34005

Palencia

46017

Valencia

46520

Sagunto

47005

Valladolid

47010

Valladolid

49021

Zamora

07198

Palma de Mallorca

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00661778 - A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter